Intermittent Oro-Esophageal Tube Feeding Using Individually-Customized 3-Dimensional Printing
Primary Purpose
Dysphagia
Status
Unknown status
Phase
Not Applicable
Locations
Korea, Republic of
Study Type
Interventional
Intervention
VFSS
Sponsored by
About this trial
This is an interventional treatment trial for Dysphagia focused on measuring dysphagia, intermittent tube, individual 3D printed guiding tube
Eligibility Criteria
Inclusion Criteria:
- Dysphagia patients to check in VFSS (videofluoroscopic swallow study)
- Patients participating in the study agreement
- Oral feeding is not possible (Need tube feeding)
Exclusion Criteria:
- Patient to reject the participation
- Crico-pharyngeal incoordination
- Impaired esophageal peristalsis
- Impaired GI tract
- Observed esophageal reflux
Sites / Locations
- Ulsan University HospitalRecruiting
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm Type
Experimental
Active Comparator
Active Comparator
Arm Label
Individual 3D-printed guided tube
traditional IOE tube
nasogastric tube
Arm Description
IOE tube feeding using individual 3D-printed guided tube and nelaton tube whenever they eat
classic IOE tube feeding using nelaton tube only whenever they eat
nasogastric tube feeding using levin tube always
Outcomes
Primary Outcome Measures
change of EORTC QLQ - H&N35 index
Details (inconvenience, discomfort, altered body image, social activities, family life, pain, ease of learning to use) satisfaction evaluation (3, 9, 10)
Secondary Outcome Measures
complications
whether aspiration pneumonia on Chest Radiography or not, Measurement at leave hospital or start oral feeding can be another endpoint
change Mid-arm circumference
change of Serum albumin
change of MRS index
change of success rate (rate of elimination)
change of EORTC QLQ - H&N35 index
Measurement at leave hospital or start oral feeding can be another endpoint, Details (inconvenience, discomfort, altered body image, social activities, family life, pain, ease of learning to use) satisfaction evaluation (3, 9, 10)
Full Information
NCT ID
NCT02822456
First Posted
June 14, 2016
Last Updated
December 2, 2019
Sponsor
Ulsan University Hospital
1. Study Identification
Unique Protocol Identification Number
NCT02822456
Brief Title
Intermittent Oro-Esophageal Tube Feeding Using Individually-Customized 3-Dimensional Printing
Official Title
Intermittent Oro-Esophageal Tube Feeding Using Individually-Customized 3-Dimensional Printing: Prospective, Single Center, Observational Trial of Superiority
Study Type
Interventional
2. Study Status
Record Verification Date
December 2019
Overall Recruitment Status
Unknown status
Study Start Date
December 2015 (undefined)
Primary Completion Date
December 2020 (Anticipated)
Study Completion Date
December 2020 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Ulsan University Hospital
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
The aim of this study is to test the clinical effectiveness of IOE tube using individually customized 3-dimentional printed guiding tube as an alternative to Levin tube feeding when unconscious patients have no choice but tube feeding.
Detailed Description
According to standard Guideine of videofluoroscopic swallow study(VFSS), Patients referred to dysphagia(swallowing dysfunction)who were required to tube feeding and medically stable of vital sign, and agreed to participate. Participants with swallowing dysfunction who were classified into three groups (nasogastric tube, traditional intermittent (IOE) tube, individual 3D printed guiding tube) according to VFSS.
Both traditional IOE tube and individual 3D printed guiding tube groups will receive training about procedure prior to the first feeding. All participants will be evaluated with satisfaction for tube feeding (EORTC QLQ-H&N35) in 3 days from the start day of the tube feeding. On the day of oral feeding, participants will be evaluated with the questionnaires and clinical examination. If the participant is discharged in a state maintain the tube feeding, investigated further length stay at leaving the hospital. On the 1 month, 3 month from tube feeding, the investigators will follow-up and measure the questionnaires and clinical examination.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Dysphagia
Keywords
dysphagia, intermittent tube, individual 3D printed guiding tube
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
24 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Individual 3D-printed guided tube
Arm Type
Experimental
Arm Description
IOE tube feeding using individual 3D-printed guided tube and nelaton tube whenever they eat
Arm Title
traditional IOE tube
Arm Type
Active Comparator
Arm Description
classic IOE tube feeding using nelaton tube only whenever they eat
Arm Title
nasogastric tube
Arm Type
Active Comparator
Arm Description
nasogastric tube feeding using levin tube always
Intervention Type
Procedure
Intervention Name(s)
VFSS
Intervention Description
VFSS using assignment of tube type among the interventions such as individual 3D printed guiding tube, traditional IOE tube, levin tube
Primary Outcome Measure Information:
Title
change of EORTC QLQ - H&N35 index
Description
Details (inconvenience, discomfort, altered body image, social activities, family life, pain, ease of learning to use) satisfaction evaluation (3, 9, 10)
Time Frame
1 month after start of tube feeding
Secondary Outcome Measure Information:
Title
complications
Description
whether aspiration pneumonia on Chest Radiography or not, Measurement at leave hospital or start oral feeding can be another endpoint
Time Frame
after 1st session (3days) and after 1 month, and after 3 months
Title
change Mid-arm circumference
Time Frame
before VFSS and 1 month and 3 months after start of tube feeding
Title
change of Serum albumin
Time Frame
before VFSS and 1 month and 3 months after start of tube feeding
Title
change of MRS index
Time Frame
before VFSS and 1 month and 3 months after start of tube feeding
Title
change of success rate (rate of elimination)
Time Frame
after 1st session (3days), after 1 month, and after 3 months
Title
change of EORTC QLQ - H&N35 index
Description
Measurement at leave hospital or start oral feeding can be another endpoint, Details (inconvenience, discomfort, altered body image, social activities, family life, pain, ease of learning to use) satisfaction evaluation (3, 9, 10)
Time Frame
after 1st session (3days) and after 3 months
10. Eligibility
Sex
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Dysphagia patients to check in VFSS (videofluoroscopic swallow study)
Patients participating in the study agreement
Oral feeding is not possible (Need tube feeding)
Exclusion Criteria:
Patient to reject the participation
Crico-pharyngeal incoordination
Impaired esophageal peristalsis
Impaired GI tract
Observed esophageal reflux
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Chang Ho Hwang
Phone
+82-52-250-8898
Email
chhwang1220ciba@gmail.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Chang Ho Hwang, M.D., Ph.D.
Organizational Affiliation
Ulsan University Hospital
Official's Role
Study Director
Facility Information:
Facility Name
Ulsan University Hospital
City
Ulsan
ZIP/Postal Code
682-714
Country
Korea, Republic of
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Chang Ho Hwang, M.D., Ph.D.
Phone
+82-52-250-7210
Email
chhwang1220ciba@gmail.com
First Name & Middle Initial & Last Name & Degree
Chang Ho Hwang, M.D., Ph.D.
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Intermittent Oro-Esophageal Tube Feeding Using Individually-Customized 3-Dimensional Printing
We'll reach out to this number within 24 hrs